Bleeding Time Study With AZD6482, Clopidogrel and ASA

NCT00853450 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Antiplatelet Effect

Interventions

DRUG: AZD6482
DRUG: Clopidogrel
DRUG: ASA

Sponsor

AstraZeneca